The problem is on a scale of priorities BIS to monitor lymphoedema will be well down the list. Hospitals are too busy savings lives and keeping people alive. Funding will go to critical needs first. The market is not there for lymphoedema alone to be a company maker… either they face reality and scale down the business to suit demand or shareholders face never ending dilution into oblivion.
IPD Price at posting:
5.1¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)